0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 10 mL, Single-Dose Vial, NDC 0409-9045-01, Hospira, Inc., Lake Forest, IL 60045
Published October 16, 2013 · Recall initiated: September 5, 2013
Summary
FDA records drug Class II recall D-66295-001, published October 16, 2013 and initiated September 5, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 187,150 vials; Lot: Lot 17-400-EV* and 17-401-EV * Note: the lot number may be followed by 01. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility; potential for vial breakage
What to do
Voluntary: Firm initiated · Letter
Get an email if BUPIVACAINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUPIVACAINE HYDROCHLORIDE
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide and Guam and Abu Dhabi
- Lot
- Lot 17-400-EV* and 17-401-EV * Note: the lot number may be followed by 01
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx only,April 22, 2026
- FDABupivacaine HCl Injection, single dose vial, Preservative Free 0.5%, 10mL (25/ct), Rx only, Manufacturer:June 15, 2022
- FDABupivacaine Hydrochloride, USP 0.5% (5mg/mL), 25 vials x 50 mL per box, Rx only, MFG: Pfizer, NDC 0409-1163-01June 15, 2022
- FDABupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials,December 28, 2016
- FDANext Choice" One Dose Emergency Contraceptive (Levonorgestrel Tablet), 1.5 mg, 1 Tablet/Blister Card (NDCOctober 16, 2013
- FDADeVilbiss Vacu-Aide QSU Suction Unit (Disposable Suction Container/Filter), 800 ML DISP Container,October 9, 2013
Questions about this recall
Was 0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 10 mL, Single-Dose Vial, NDC 0409-9045-01, Hospira, Inc., Lake Forest, IL 60045 recalled?
Yes. FDA published recall D-66295-001 on October 16, 2013. Reported hazard: Lack of Assurance of Sterility; potential for vial breakage
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUPIVACAINE HYDROCHLORIDE.